Portfolio (Quarterly)
Guide ↗
Opaleye Management Inc.
· CIK 0001595855| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | CRESCENT BIOPHARMA INC | — | 1,178,300.0 | $14.0M | 1.84% | NEW | — | $11.86 | — |
| 2 | KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | 930,000.0 | $6.8M | 0.90% | NEW | — | $7.36 | +9.5% |
| 3 | JBIO | JADE BIOSCIENCES INC | Healthcare | 427,608.0 | $6.6M | 0.87% | NEW | — | $15.43 | +52.0% |
| 4 | URGN | UROGEN PHARMA LTD | Healthcare | 268,423.0 | $6.3M | 0.83% | NEW | — | $23.42 | +29.0% |
| 5 | CATX | PERSPECTIVE THERAPEUTICS INC | Healthcare | 1,184,500.0 | $5.0M | 0.66% | NEW | — | $4.21 | -8.1% |
| 6 | VYGR | VOYAGER THERAPEUTICS INC | Healthcare | 1,196,904.0 | $4.7M | 0.62% | NEW | — | $3.93 | -10.9% |
| 7 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 935,000.0 | $4.5M | 0.60% | NEW | — | $4.83 | +48.4% |
| 8 | TECX | TECTONIC THERAPEUTICS INC | Healthcare | 214,747.0 | $4.5M | 0.59% | NEW | — | $20.86 | +38.3% |
| 9 | — | FORTRESS BIOTECH INC | — | 1,090,000.0 | $4.0M | 0.53% | NEW | — | $3.66 | — |
| 10 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 955,000.0 | $3.4M | 0.44% | NEW | — | $3.51 | -15.4% |
| 11 | MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | 390,844.0 | $3.1M | 0.41% | NEW | — | $7.95 | +19.4% |
| 12 | ASRT | ASSERTIO HOLDINGS INC | Healthcare | 285,000.0 | $2.6M | 0.34% | NEW | — | $9.07 | +157.7% |
| 13 | — | VENTYX BIOSCIENCES INC | — | 251,932.0 | $2.3M | 0.30% | NEW | — | $9.03 | — |
| 14 | — | SUTRO BIOPHARMA INC | — | 190,671.0 | $2.2M | 0.29% | NEW | — | $11.57 | — |
| 15 | — | GENERATION BIO CO | — | 310,000.0 | $1.8M | 0.23% | NEW | — | $5.68 | — |
| 16 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 18,319.0 | $1.4M | 0.18% | NEW | — | $76.49 | -8.1% |
| 17 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 75,000.0 | $1.2M | 0.16% | NEW | — | $15.77 | -12.3% |
| 18 | QTTB | Q32 BIO INC | Healthcare | 213,363.0 | $708K | 0.09% | NEW | — | $3.32 | +70.8% |
| 19 | AVIR | ATEA PHARMACEUTICALS INC | Healthcare | 179,815.0 | $642K | 0.09% | NEW | — | $3.57 | +18.8% |
| 20 | SLN | SILENCE THERAPEUTICS PLC | Healthcare | 78,926.0 | $480K | 0.06% | NEW | — | $6.08 | +2.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%